Alkermes (STU:8AK) Accounts Payable & Accrued Expense : €368 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Alkermes Accounts Payable & Accrued Expense?

Alkermes's quarterly accounts payable & accrued expense declined from Sep. 2023 (€388 Mil) to Dec. 2023 (€386 Mil) and declined from Dec. 2023 (€386 Mil) to Mar. 2024 (€368 Mil).

Alkermes's annual accounts payable & accrued expense increased from Dec. 2021 (€326 Mil) to Dec. 2022 (€371 Mil) and increased from Dec. 2022 (€371 Mil) to Dec. 2023 (€386 Mil).

Alkermes Accounts Payable & Accrued Expense Historical Data

The historical data trend for Alkermes's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Accounts Payable & Accrued Expense Chart

Alkermes Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

270.87

280.30

326.08

371.10

386.14

Alkermes Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															396.68	374.49	387.88	386.14	367.56

Alkermes Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Alkermes (STU:8AK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ALKS:USA 8AK:Germany

Address

1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6

Website

https://www.alkermes.com

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines